Revised PBS Restrictions for Pulmonary Arterial Hypertension (PAH) Medicines

Page last updated: 1 May 2020

PBS restrictions for PAH medicines have changed as an outcome of the Post-market Review of PAH medicines. Effective 1 May 2020, access to these medicines will improve through closer alignment of PBS restrictions with clinical guidelines. Refer to the factsheet for further details on these changes.

• Factsheet - Revised PBS Restrictions for Pulmonary Arterial Hypertension (PAH) Medicines (PDF 183KB) - (Word 151KB)